Capsule Microbiota Sampling in IBS/Functional Gastrointestinal Disease

Part of paid clinical trials in Redwood City, California.

Sponsor
Stanford University
Study ID
NCT06215222
Status
Recruiting
Apply to this trial

Conditions

  • Functional Bloating
  • Functional Gastrointestinal Disorders
  • Healthy
  • IBS - Irritable Bowel Syndrome

Eligibility Criteria

Sex
ALL
Age
18 Years - 70 Years
Healthy Volunteers
Accepted

Interventions

  • Microbiota Sampling — OTHER
    We will sample the Saliva, Feces, and intestinal microbiome for genetic microbiome analysis and bacterial isolation

Study Details

We will sample intestinal microbiota using a microbiome sampling capsule in Healthy, Irritable Bowel Syndrome (IBS), and Functional Gastrointestinal Disease.

Key Dates

Start date
Nov 16, 2023
Status verified
Jan 2024
Primary completion
Dec 1, 2025
Completion
Dec 1, 2026

Study Design

Enrollment
40 participants (estimated)

Arms

  • Arm: Healthy patients
    Healthy Patients
  • Arm: IBS/Functional GI diasease
    Patients with IBS or Functional GI disease (bloating, diarrhea, constipation)

Primary Outcome Measure

Collection of 50ul of intestinal fluid from >90% of microbiome sampling capsules [ Time Frame: 1-4 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Stanford Digestive Health ClinicRedwood CityCalifornia94063
Sean Spencer, MD/PhD
[email protected]
650-736-5555
Linda Nguyen, MD
(650) 736-5555
Sean Spencer, MD/PhD (PRINCIPAL_INVESTIGATOR)
Linda Nugyen, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Redwood City, CA

By research site
Stanford Digestive Health Clinic· Redwood City, CA

Related Studies